Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 544050)

Published in Proc Natl Acad Sci U S A on December 23, 2004

Authors

Andrey A Sharov1, Michael Fessing, Ruzanna Atoyan, Tatyana Y Sharova, Carrie Haskell-Luevano, Lorin Weiner, Keiko Funa, Janice L Brissette, Barbara A Gilchrest, Vladimir A Botchkarev

Author Affiliations

1: Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA.

Articles citing this

The serine protease Corin is a novel modifier of the Agouti pathway. Development (2007) 1.69

Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors. J Control Release (2012) 1.61

p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol (2011) 1.39

Bone morphogenetic protein signaling regulates the size of hair follicles and modulates the expression of cell cycle-associated genes. Proc Natl Acad Sci U S A (2006) 1.35

Beta-catenin activity in the dermal papilla of the hair follicle regulates pigment-type switching. Proc Natl Acad Sci U S A (2010) 1.19

Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development (2011) 1.15

Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signaling. Mol Biol Cell (2007) 1.14

Bone morphogenetic protein antagonist noggin promotes skin tumorigenesis via stimulation of the Wnt and Shh signaling pathways. Am J Pathol (2009) 1.04

Involvement of the Edar signaling in the control of hair follicle involution (catagen). Am J Pathol (2006) 1.01

BMP signaling induces cell-type-specific changes in gene expression programs of human keratinocytes and fibroblasts. J Invest Dermatol (2009) 0.93

p63 and Brg1 control developmentally regulated higher-order chromatin remodelling at the epidermal differentiation complex locus in epidermal progenitor cells. Development (2014) 0.92

Bone morphogenetic protein signaling suppresses wound-induced skin repair by inhibiting keratinocyte proliferation and migration. J Invest Dermatol (2013) 0.89

Cbx4 maintains the epithelial lineage identity and cell proliferation in the developing stratified epithelium. J Cell Biol (2015) 0.88

Akt2 and SGK3 are both determinants of postnatal hair follicle development. FASEB J (2009) 0.83

A multi-scale model for hair follicles reveals heterogeneous domains driving rapid spatiotemporal hair growth patterning. Elife (2017) 0.82

Genome-wide analysis of long non-coding RNAs at early stage of skin pigmentation in goats (Capra hircus). BMC Genomics (2016) 0.81

Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes. Int J Cell Biol (2009) 0.80

A pair of transmembrane receptors essential for the retention and pigmentation of hair. Genesis (2012) 0.79

Complex changes in the apoptotic and cell differentiation programs during initiation of the hair follicle response to chemotherapy. J Invest Dermatol (2014) 0.77

p63 transcription factor regulates nuclear shape and expression of nuclear envelope-associated genes in epidermal keratinocytes. J Invest Dermatol (2017) 0.75

Skin as a living coloring book: how epithelial cells create patterns of pigmentation. Pigment Cell Melanoma Res (2014) 0.75

5C analysis of the Epidermal Differentiation Complex locus reveals distinct chromatin interaction networks between gene-rich and gene-poor TADs in skin epithelial cells. PLoS Genet (2017) 0.75

Articles cited by this

Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94

New insights into TGF-beta-Smad signalling. Trends Biochem Sci (2004) 6.13

A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12

The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell (1996) 5.66

Getting under the skin of epidermal morphogenesis. Nat Rev Genet (2002) 4.54

Dominant role of the niche in melanocyte stem-cell fate determination. Nature (2002) 4.05

Morphogenesis. Cell (1999) 4.00

Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev (1998) 3.46

Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol (1989) 3.21

Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99

Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. J Cell Biol (2003) 2.65

At the roots of a never-ending cycle. Dev Cell (2001) 2.23

Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20

Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene (2003) 2.19

Inhibition of Bmp signaling affects growth and differentiation in the anagen hair follicle. EMBO J (2000) 2.01

Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95

Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol (1999) 1.80

Differences in dorsal and ventral pigmentation result from regional expression of the mouse agouti gene. Proc Natl Acad Sci U S A (1994) 1.77

Morpho-regulation of ectodermal organs: integument pathology and phenotypic variations in K14-Noggin engineered mice through modulation of bone morphogenic protein pathway. Am J Pathol (2004) 1.72

Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. J Invest Dermatol (2003) 1.60

Evo-devo of feathers and scales: building complex epithelial appendages. Curr Opin Genet Dev (2000) 1.56

Expression and transgenic studies of the mouse agouti gene provide insight into the mechanisms by which mammalian coat color patterns are generated. Development (1995) 1.55

SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J (2001) 1.54

alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem (1998) 1.34

Biochemical control of melanogenesis and melanosomal organization. J Investig Dermatol Symp Proc (1999) 1.29

Opposite orientations of an inverted duplication and allelic variation at the mouse agouti locus. Genetics (1996) 1.27

Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J (2003) 1.27

Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo. Dev Biol (2001) 1.25

Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles. J Invest Dermatol (2002) 1.25

Mice null for sox18 are viable and display a mild coat defect. Mol Cell Biol (2000) 1.24

Spectrophotometric characterization of eumelanin and pheomelanin in hair. Pigment Cell Res (1996) 1.19

Role of the nude gene in epithelial terminal differentiation. J Invest Dermatol (2002) 1.03

Fate of melanocytes during development of the hair follicle pigmentary unit. J Investig Dermatol Symp Proc (2003) 0.97

Biochemical and genetic studies of pigment-type switching. Pigment Cell Res (2000) 0.94

The fate of hair follicle melanocytes during the hair growth cycle. J Investig Dermatol Symp Proc (1999) 0.91

Novel agouti-related-protein-based melanocortin-1 receptor antagonist. J Med Chem (2001) 0.88

Differential responses of collagen and glycosaminoglycan syntheses and cell proliferation to exogenous transforming growth factor beta 1 in the developing mouse skin fibroblasts in culture. Br J Plast Surg (1999) 0.83

Cell mass, hair type and expression of the agouti gene. Nature (1969) 0.79

Articles by these authors

The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol (2008) 2.34

A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol (2006) 2.29

Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest (2007) 2.28

Integration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation control. Dev Cell (2005) 2.21

Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells (2006) 2.07

Academic dermatology manpower: issues of recruitment and retention. Arch Dermatol (2007) 2.02

Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. J Invest Dermatol (2009) 1.96

Dedicated epithelial recipient cells determine pigmentation patterns. Cell (2007) 1.78

Melanoma incidence and mortality among US whites, 1969-1999. JAMA (2002) 1.74

Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol (2005) 1.68

The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol (2006) 1.66

Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol (2007) 1.54

Ultraviolet-fluorescent tattoo location of cutaneous biopsy site. Dermatol Surg (2011) 1.51

Remodeling of three-dimensional organization of the nucleus during terminal keratinocyte differentiation in the epidermis. J Invest Dermatol (2013) 1.51

Genome organizing function of SATB1 in tumor progression. Semin Cancer Biol (2012) 1.45

Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration. Blood (2010) 1.44

Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem (2005) 1.42

Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry (2006) 1.42

Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol (2007) 1.41

Pitfalls of evidence-based medicine: the example of actinic keratosis therapy. Arch Dermatol (2012) 1.40

p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol (2011) 1.39

Evidence that exposure of the telomere 3' overhang sequence induces senescence. Proc Natl Acad Sci U S A (2003) 1.37

Bone morphogenetic protein signaling regulates the size of hair follicles and modulates the expression of cell cycle-associated genes. Proc Natl Acad Sci U S A (2006) 1.35

alpha-MSH tripeptide analogs activate the melanocortin 1 receptor and reduce UV-induced DNA damage in human melanocytes. Pigment Cell Melanoma Res (2009) 1.32

Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J (2003) 1.27

Network modeling of the transcriptional effects of copy number aberrations in glioblastoma. Mol Syst Biol (2011) 1.26

Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles. J Invest Dermatol (2002) 1.25

Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem (2001) 1.23

Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB J (2007) 1.22

Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol (2003) 1.22

Telomere-based DNA damage responses: a new approach to melanoma. FASEB J (2004) 1.21

ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters. J Biol Chem (2008) 1.21

Developmental timing of hair follicle and dorsal skin innervation in mice. J Comp Neurol (2002) 1.20

p75 Neurotrophin receptor antagonist retards apoptosis-driven hair follicle involution (catagen). J Invest Dermatol (2003) 1.16

Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development (2011) 1.15

A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol (2004) 1.14

Improving skin cancer prevention and detection education in US medical schools. Arch Dermatol (2006) 1.14

Induction of apoptosis by telomere 3' overhang-specific DNA. Exp Cell Res (2002) 1.14

An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer. Mol Cell Biol (2006) 1.13

Unity in action. J Invest Dermatol (2014) 1.12

The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol (2002) 1.11

MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. Biochem J (2006) 1.11

Fifty years of skin aging. J Investig Dermatol Symp Proc (2002) 1.10

Expression of deltaNp73 predicts poor prognosis in lung cancer. Clin Cancer Res (2004) 1.09

A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans. J Clin Invest (2009) 1.09

CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity. Cancer Res (2010) 1.09

p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. J Biol Chem (2002) 1.09

Pathobiology of chemotherapy-induced hair loss. Lancet Oncol (2013) 1.08

Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase activity and phosphatidylinositol 3-kinase signaling. Clin Cancer Res (2012) 1.08

Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer (2009) 1.08

Food demand and meal size in mice with single or combined disruption of melanocortin type 3 and 4 receptors. Am J Physiol Regul Integr Comp Physiol (2010) 1.07

Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res (2007) 1.06

A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer (2006) 1.05

Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res (2004) 1.05

Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. Proc Natl Acad Sci U S A (2004) 1.04

Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. FASEB J (2003) 1.04

Bone morphogenetic protein antagonist noggin promotes skin tumorigenesis via stimulation of the Wnt and Shh signaling pathways. Am J Pathol (2009) 1.04

A role for WRN in telomere-based DNA damage responses. Proc Natl Acad Sci U S A (2006) 1.03

Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies. Med Res Rev (2004) 1.03

Role of the nude gene in epithelial terminal differentiation. J Invest Dermatol (2002) 1.03

CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy. Clin Cancer Res (2009) 1.02

Implication of the melanocortin-3 receptor in the regulation of food intake. Eur J Pharmacol (2011) 1.02

Involvement of the Edar signaling in the control of hair follicle involution (catagen). Am J Pathol (2006) 1.01

Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am J Pathol (2004) 1.00

The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol (2003) 1.00

TLX activates MASH1 for induction of neuronal lineage commitment of adult hippocampal neuroprogenitors. Mol Cell Neurosci (2010) 0.99

Kit is expressed by epithelial cells in vivo. J Invest Dermatol (2003) 0.98

Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. J Med Chem (2008) 0.98

p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y. J Biol Chem (2002) 0.98

ASK1 inhibits astroglial development via p38 mitogen-activated protein kinase and promotes neuronal differentiation in adult hippocampus-derived progenitor cells. Mol Cell Biol (2004) 0.98

Fate of melanocytes during development of the hair follicle pigmentary unit. J Investig Dermatol Symp Proc (2003) 0.97

delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg (2004) 0.97

T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. J Biol Chem (2005) 0.96

Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. J Med Chem (2004) 0.95

Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1. J Biol Chem (2010) 0.94

Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program. Cancer (2002) 0.94

The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp Neurol (2004) 0.94

Ghrelin-induced food intake and growth hormone secretion are altered in melanocortin 3 and 4 receptor knockout mice. Peptides (2005) 0.93

Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells. J Cell Physiol (2007) 0.93

Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity. FASEB J (2006) 0.93